863307-01-1Relevant articles and documents
Design of Potent and Selective Covalent Inhibitors of Bruton's Tyrosine Kinase Targeting an Inactive Conformation
Pulz, Robert,Angst, Daniela,Dawson, Janet,Gessier, Francois,Gutmann, Sascha,Hersperger, Rene,Hinniger, Alexandra,Janser, Philipp,Koch, Guido,Revesz, Laszlo,Vulpetti, Anna,Waelchli, Rudolf,Zimmerlin, Alfred,Cenni, Bruno
, p. 1467 - 1472 (2019/10/11)
Bruton's tyrosine kinase (BTK) is a member of the TEC kinase family and is selectively expressed in a subset of immune cells. It is a key regulator of antigen receptor signaling in B cells and of Fc receptor signaling in mast cells and macrophages. A BTK
7H-PYRROLOPYRIMIDINE DERIVATIVES
-
Page/Page column 31-32, (2008/06/13)
The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula (I), wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives a